Latest Apicomplexa Stories
A novel anti-inflammatory drug could help to improve survival in the most severe cases of malaria by preventing the immune system from causing irrevocable brain and tissue damage.
Poor quality antimalarial drugs lead to drug resistance and inadequate treatment that pose an urgent threat to vulnerable populations, according to a National Institutes of Health study published May 22 in The Lancet Infectious Diseases journal.
Biologists at the University of California, San Diego have succeeded in engineering algae to produce potential candidates for a vaccine that would prevent transmission of the parasite that causes malaria, an achievement that could pave the way for the development of an inexpensive way to protect billions of people from one of the world's most prevalent and debilitating diseases.
Biologists at the University of California, San Diego have revealed their progress in engineering algae for a vaccine that could possibly counter transmission of the parasite that causes malaria.
Last year it killed an estimated 655,000 people. Now researchers are developing new ways to block the transmission of Plasmodium, the parasite responsible for human malaria.
Over 200 million people contract malaria each year, and according to the World Health Organization, an estimated 655,000 people died from malaria in 2010.
Online crowd-sourcing — in which a task is presented to the public, who respond, for free, with various solutions and suggestions — has been used to evaluate potential consumer products, develop software algorithms and solve vexing research-and-development challenges.
Research of wounds on a 5,300-year-old body found frozen in the Italian Alps in 1991 has produced the oldest red blood cells ever identified, and suggests the well preserved “Iceman” did not immediately die from his injuries, nor did he live for a few days.
- A volcanic mudflow.
More Images (1 images) »